Kazatomprom
Integrated in-situ recovery (ISR/ISL) uranium producer selling U3O8 (and some conversion/fuel products) to nuclear utilities and traders under a mix of long-term contracts (priced off spot with lags/floors/ceilings) and spot sales; operates through a lattice of JVs with global majors and sells through its Swiss/Kazakh trading arm. State majority-owned (Samruk-Kazyna) with GDRs floated to the public.
Earnings, margins, COGS & capex
FY2025 was a flat-revenue, high-margin year: consolidated revenue KZT 1,803.0B (-1%) with adjusted EBITDA up 3% to KZT 1,133.5B (~63% margin) and operating cash flow up 57% to KZT 809.8B. Headline net profit fell 29% to KZT 806.7B purely because 2024 carried a one-time gain (Budenovskoye JV consolidation); adjusted net profit attributable to owners was roughly stable at KZT 570.5B. The balance sheet is net cash (~KZT 140B at 31-Dec-2025). The forward story is price, not volume: realized prices ($61.33/lb in 1Q2026) still lag spot ($88.49/lb), so contracted revenue should catch up as legacy contracts roll, and FY2026 revenue guidance jumps to KZT 2,200-2,300B even as the company deliberately trims its nominal output plan ~10%.
Income statement — where each revenue dollar goes
% of revenueOf every $1 of revenue, ~37¢ is cost of goods and ~20¢ operating expense, leaving ~43¢ of operating profit (~45¢ net).
Revenue trend
Margins
up (+3% EBITDA YoY)
roughly flat (-3% operating profit YoY)
down on a 2024 one-time gain; adjusted net profit stable
roughly stable YoY (2024: ~KZT 577B)
COGS structure
Dominated by mining/processing of ISR uranium and purchases from JVs; distinguishing feature is a structurally low cash cost — C1 cash cost (attributable) $18.06/lb (FY2025), guided $23.50-25.00/lb for FY2026; all-in sustaining cost (attributable) $29.53/lb (FY2025), guided $35.00-36.50/lb FY2026. Rising unit-cost guidance reflects wellfield development, sulfuric acid inflation, higher mineral extraction tax (MET) and Rosatom-linked purchase pricing, but remains well below Western hard-rock peers.
Capex
FY2025 capex KZT 398.2B (actual, within the KZT 385-415B guidance); FY2026 guidance KZT 415-430B — mine development, wellfield expansion and JV Budenovskoye ramp; ~22% of revenue.
Latest earnings
not an EPS-guidance market; company reiterated FY2026 guidance (production, sales, revenue, cost)
FY2026: production 27,500-29,000 tU (100% basis) / 14,500-15,500 tU attributable; sales 19,500-20,500 tU; revenue KZT 2,200-2,300B; C1 cash cost $23.50-25.00/lb; AISC $35.00-36.50/lb; capex KZT 415-430B
- FY2025 revenue
- KZT 1,803.0B (~$3.4B)
- FY2025 adjusted EBITDA
- KZT 1,133.5B (~63% margin)
- FY2025 operating cash flow
- KZT 809.8B (+57% YoY)
- 1Q2026 realized price
- $61.33/lb U3O8
- 1Q2026 spot (month-end avg)
- $88.49/lb U3O8
- FY2025 dividend (recommended)
- KZT 1,292.27/share, ~KZT 335.2B total, 75% of FCF
- Net cash (31-Dec-2025)
- ~KZT 140B; net debt/EBITDA -0.12x
Growth drivers
- Uranium price up-cycle — spot ~$88/lb (1Q2026) vs realized ~$61/lb creates a multi-year revenue catch-up as legacy contracts reprice and new term contracts lock higher floors
- Global nuclear buildout — China's aggressive reactor program, reactor life extensions, SMR pipeline, and AI/data-center power demand reviving nuclear as baseload
- Deliberate supply discipline — trimming the FY2026 nominal production plan ~10% (from 32,777 to 29,697 tU, 100% basis) to tighten the market and support price rather than chase volume
- Lowest-cost ISR position sustaining industry-leading margins through the cycle
- Budenovskoye JV ramp adding attributable volume into a tightening market
- ~75%-of-FCF dividend policy returning the cash-flow windfall to holders
Bull & bear
A net-cash, lowest-cost producer of the one commodity a nuclear renaissance can't do without, deliberately restraining supply while its realized price still trails spot by ~$27/lb — a built-in revenue catch-up on top of the highest margins in the sector, returned as a ~75%-of-FCF dividend.
- Owns the cost curve: ISR C1 cost around $18/lb (FY2025) means Kazatomprom prints cash at prices that would shutter Western hard-rock mines
- Price catch-up is mechanical, not speculative — 1Q2026 realized $61.33/lb vs $88.49/lb spot; as legacy contracts roll, revenue re-rates even at flat spot
- FY2026 revenue guided +22-28% to KZT 2,200-2,300B despite a deliberate ~10% cut to the nominal production plan — pricing power over volume
- ~20% of global primary supply plus supply discipline gives it real influence over the market it sells into
- Net cash, ~63% EBITDA margin, 57% jump in operating cash flow, and a 75%-of-FCF dividend (KZT 1,292.27/share for FY2025)
- Demand tailwinds are structural and multi-year: China reactors, life extensions, SMRs, and AI/data-center baseload power reviving nuclear
A single-commodity, state-controlled miner in a landlocked, geopolitically exposed jurisdiction whose earnings live and die by the uranium price, whose minority holders sit behind the Kazakh state, and whose supply chain runs through Russia amid an active Rosatom dispute.
- Pure uranium-price beta with high operating leverage — a cyclical downturn or secondary-supply release (e.g. inventory/enricher underfeeding) craters margins
- Samruk-Kazyna control means MET hikes, tax changes, and dividend discretion can be set for the state's benefit over GDR holders
- Budenovskoye JV dispute with Rosatom-linked SGCC, plus transit dependence on Russia, injects real operational and geopolitical risk
- Sulfuric acid shortages and wellfield delays have a track record of capping production — execution isn't guaranteed
- Rising unit-cost guidance (C1 to $23.50-25/lb; AISC to $35-36.50/lb) would erode the cost moat over time
- USD investors bear KZT currency and Kazakhstan country risk on top of the commodity risk; the stock is volatile and thinly understood by Western markets
What it is worth
Cross-check of P/E and EV/EBITDA on FY2025 results against the ~$18.5B LSE market cap, framed against the forward price-catch-up and dividend yield
~$11-13B
uranium price rolls over or a Rosatom/Budenovskoye/tax shock lands; multiple compresses to ~5-6x EV/EBITDA on single-commodity + country risk.
~$18-20B
roughly current; ~8x EV/EBITDA and ~12x P/E with the price catch-up and net-cash dividend support offsetting state/geopolitical discount.
~$26-30B
contract book reprices toward $80-90/lb, FY2026 revenue guidance (KZT 2,200-2,300B) proves conservative, market re-rates to ~11-12x EV/EBITDA on structural nuclear demand.
~$18.5B market cap on ~$1.54B FY2025 reported net profit is ~12x trailing P/E (higher, ~17x, on the KZT 570B adjusted attributable figure). EV of ~$18.2B (net cash ~$0.27B at 31-Dec-2025) against ~$2.16B FY2025 adjusted EBITDA is ~8x EV/EBITDA — a reasonable multiple for the lowest-cost, largest-scale producer with a mechanical revenue catch-up ($61 realized vs $88 spot) and a ~75%-of-FCF dividend. The bull case underwrites contract repricing and structural nuclear demand; the bear case discounts for state control, Russia/Rosatom risk, single-commodity cyclicality, and rising unit costs.
SWOT
Strengths
- World's largest uranium producer — ~20% of global primary supply; unmatched scale and reserve base
- Structurally lowest-cost producer via in-situ recovery — C1 cash cost around $18/lb (FY2025), far below Western hard-rock mines
- Net-cash balance sheet (~KZT 140B at 31-Dec-2025) with ~63% EBITDA margins and strong operating cash conversion
- Vast, long-life licensed resource under sovereign subsoil rights; national-champion status
- JV lattice ties in every major buyer/miner (Cameco, Orano, CGN, CNNC, Rosatom, Sumitomo), locking in demand and diversifying capital
Weaknesses
- State control (Samruk-Kazyna majority) subordinates minority GDR holders to Kazakh fiscal and strategic priorities (MET/tax changes, dividend discretion)
- Landlocked logistics — export routes historically transit Russia; sanctions/logistics risk forced costly Trans-Caspian rerouting
- Chronic sulfuric acid supply constraint has repeatedly capped/deferred production
- Realized prices lag spot sharply ($61 vs $88/lb), so the company under-monetizes rallies in the near term
- Revenue is a pure uranium-price play with high operating leverage and no meaningful downstream/diversification buffer
Opportunities
- Structural uranium bull market — reactor restarts, China buildout, SMRs, and AI/data-center electricity demand
- Contract book repricing higher as old contracts roll off into an $80-90/lb spot environment
- Supply discipline (2026 plan cut) tightening the market and supporting price for years
- Potential downstream/conversion and enrichment adjacencies, and value-added fuel products
- Growing non-Russian, non-Chinese Western utility demand for supply-chain diversification
Threats
- Uranium price cyclicality — a demand disappointment or secondary-supply release compresses margins fast
- Rosatom relationship risk — Budenovskoye JV dispute with SGCC (a Rosatom entity) plus transit dependence
- Kazakh state fiscal grabs — higher mineral extraction tax or royalty/dividend changes
- Geopolitical/transit risk in a landlocked, Russia/China-bordered jurisdiction
- Sulfuric acid and wellfield development bottlenecks capping output
- KZT currency and country risk for USD-based investors
Moats, dependencies & bottlenecks
Moats
High (multi-decade orebodies amenable to in-situ recovery) Cash cost around $18/lb (FY2025), structurally below hard-rock peers; the durable core advantage, though unit-cost guidance is drifting up.
~20% of world primary supply under sovereign subsoil rights; irreplaceable asset position.
JVs with Cameco (Inkai), Orano (Katco), CGN/CNNC, Rosatom, Sumitomo lock in offtake and share capital risk.
Supply-discipline decisions (2026 plan cut) move the market — a swing-producer lever, but constrained by state and JV politics.
Dependencies
Revenue and margins are a direct function of U3O8 price; realized prices lag spot with a mix of fixed/floor/ceiling term contracts.
Ownership/Regulatory Majority owner sets tax (MET), subsoil terms, and dividend policy; minority GDR holders are subordinate.
Partner/Geopolitical Active dispute over Budenovskoye; export logistics historically route via Russia — sanctions forced Trans-Caspian rerouting.
Input/Supply-chain Chronic domestic acid shortage has repeatedly constrained ISR output (though 2026 supply is guided stable).
Customer concentration China (CGN/CNNC) is a top export market and JV partner; demand and pricing leverage tilt eastward.
Advantages
- Lowest cash-cost uranium production in the world (ISR, ~$18/lb C1 in FY2025)
- ~20% share of global primary supply — swing-producer scale
- Net-cash balance sheet and ~63% EBITDA margins
- Deep JV relationships spanning every major utility/miner bloc
- Contract book positioned to reprice higher into a tight market
Weaknesses
- Single-commodity concentration with high operating leverage
- State control subordinating minority holders
- Geopolitical/transit exposure (Russia, China borders; landlocked)
- Realized prices lag spot, under-monetizing rallies near-term
- Input bottlenecks (acid) and rising cost guidance
Bottlenecks
- Sulfuric acid supply — recurring shortage that caps in-situ leach production
- Wellfield development and permitting pace, including the Budenovskoye JV ramp
- Export logistics/transit — landlocked routing away from Russia (Trans-Caspian) adds cost and complexity
- Rising unit costs (labor, acid, MET) eroding the cost advantage
- Skilled-labor and equipment availability in remote southern Kazakhstan fields
Top signals & trends
Top signals
Bullish (price) · Deliberate supply discipline to tighten the market rather than chase volume.
Large gap = embedded future revenue catch-up as contracts roll higher.
Confirms cash return of the cyclical windfall; subject to AGM approval.
Litigation risk to a key growth JV and a reminder of Rosatom entanglement.
Mildly bearish · Cost moat narrowing, though still well inside the industry cost curve.
Balance-sheet and cash-generation strength through the cycle.
Trends
China reactor program, life extensions, SMR pipeline, and AI/data-center baseload demand lifting long-run uranium demand; 38 governments now endorse the triple-nuclear-capacity-by-2050 declaration.
Years of underinvestment plus producer discipline keep primary supply short of reactor requirements; spot ~$88/lb, long-term ~$91.50/lb.
Utilities want non-Russian fuel — an opening for Kazakh supply, but Kazatomprom's own Russia transit/Rosatom links complicate the 'Western-safe' label.
Physical trusts absorbing spot pounds tightens the market and supports price.
Higher MET/taxes and input inflation across producing jurisdictions squeeze unit economics.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
Critical ISR leaching input; chronic shortage is a production bottleneck (2026 supply guided stable).
Rosatom-linked) Budenovskoye JV counterparty; subject of a 2026 dispute.
wellfield and mine-services contractors Provide ISR development and operations capacity.
Major export customer and JV partner (context only).
State utility buyer and JV partner in Kazakh assets (context only).
JV partner (Inkai) and offtaker of Kazakh pounds.
Large Western utility buyer of front-end fuel.
Contract buyers seeking supply diversification.
The Western supermajor and Kazatomprom's Inkai JV partner; #2 global producer plus Westinghouse fuel-cycle exposure — both partner and competitor for utility contracts.
State-owned French miner/enricher; Katco JV partner in Kazakhstan and a competing supplier of front-end fuel services.
Developer of the tier-one Rook I/Arrow project in Canada's Athabasca Basin — future high-grade Western supply that could dilute Kazatomprom's share next decade.
US ISR producer/consolidator positioned as domestic-supply champion for US utilities.
Namibia's Langer Heinrich (ISR-adjacent) restarted producer plus Canadian assets (Fission).
Athabasca ISR developer (Wheeler River/Phoenix) plus physical uranium holdings.
Leading US conventional uranium (and rare-earths) producer; domestic-supply narrative.
Hong Kong-listed (1164.HK) uranium arm of China General Nuclear; both a JV partner/customer and a competing sourcer of pounds (context only, not a US buy/own call).